🇺🇸 FDA
Patent

US 7354578

Method of tumor regression with VEGF inhibitors

granted A61KA61K2039/505A61K38/179

Quick answer

US patent 7354578 (Method of tumor regression with VEGF inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K38/179, A61P, A61P35/00